head and neck cancer

Turnstone lays off 60% of staff, shakes up C-suite to keep cancer cell therapy on track
Fierce Biotech
Fri, 10/11/24 - 11:07 am
Turnstone Biologics
layoffs
colorectal cancer
head and neck cancer
uveal melanoma
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Fierce Pharma
Tue, 10/8/24 - 11:19 am
Merck
clinical trials
Keytruda
head and neck cancer
Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead
BioSpace
Fri, 07/12/24 - 11:26 am
IMMUTEP
head and neck cancer
eftilagimod alfa
clinical trials
Merck KGaA cans head and neck cancer drug once hailed as big hope
Pharmaphorum
Tue, 06/25/24 - 11:49 am
Merck KGaA
head and neck cancer
clinical trials
xevinapant
Moderna jumps as vaccine shows benefit in head and neck cancer in early study
Reuters
Tue, 04/9/24 - 05:43 pm
Moderna Therapeutics
Merck
clinical trials
vaccines
head and neck cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Transgene and NEC extend collaboration to develop head and neck cancer vaccine
Biopharma Reporter
Wed, 01/10/24 - 09:20 am
Transgene
NEC
head and neck cancer
clinical trials
TG4050
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Fri, 09/29/23 - 10:22 am
Adlai Nortye
IPOs
Novartis
AN2025
head and neck cancer
solid tumors
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
Alentis’ ALE.C04 receives fast track designation from FDA
Pharmaceutical Business Review
Fri, 08/25/23 - 09:44 am
Alentis Therapeutics
FDA
ALE.C04
metastatic head and neck squamous cell carcinoma
head and neck cancer
Galera Lays Off 70% of Staff After FDA Rejection in Severe Oral Mucositis
BioSpace
Thu, 08/10/23 - 11:32 am
Galera Therapeutics
avasopasem manganese
layoffs
oral mucositis
head and neck cancer
FDA
FDA Action Alert: Mesoblast, Sage/Biogen and Galera
BioSpace
Mon, 07/31/23 - 10:05 am
FDA
graft vs host disease
head and neck cancer
postpartum depression
major depressive disorder
Mesoblast
remestemcel-L
Biogen
SAGE Therapeutics
zuranolone
Galera Therapeutics
avasopasem manganese
CEL-SCI's multi-decade Multikine journey extends with FDA request for new trial
Fierce Biotech
Sun, 07/16/23 - 03:08 pm
Cel-Sci
Multikine
head and neck cancer
FDA
clinical trials
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
BioSpace
Mon, 07/10/23 - 09:36 pm
JNJ
Nanobiotix
NBTXR3
radiotherapy
head and neck cancer
Eisai goes after head and neck cancer in Made of More campaign
Medical Marketing and Media
Mon, 06/12/23 - 11:24 pm
Eisai
head and neck cancer
pharma marketing
ASCO 2023 – Bicara eyes head and neck niche
EP Vantage
Mon, 06/5/23 - 09:59 am
ASCO 2023
Bicara Therapeutics
BCA101
head and neck cancer
Eyeing untapped niche, EpicentRx makes case for cancer toxicity prevention drug
Fierce Biotech
Fri, 01/20/23 - 10:40 am
EpicentRx
clinical trials
head and neck cancer
oral mucositis
RRx-001
Cue's IL-2-based Biologic Shows Early Promise in Head and Neck Cancer
BioSpace
Sun, 11/13/22 - 07:06 pm
Cue Biopharma
CUE-101
head and neck cancer
ESMO: Merck's Keytruda chalks up failure in head and neck cancer. But experts see silver lining
Fierce Pharma
Mon, 09/12/22 - 10:52 am
Merck
Keytruda
head and neck cancer
ESMO
Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
Yahoo Finance
Fri, 09/9/22 - 11:03 am
ESMO
Adaptimmune
clinical trials
ADP-A2M4CD8
ovarian cancer
head and neck cancer
urothelial cancer

Pages